MICHAEL JOHNSON

Concepts (443)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dementia
15
2021
484
2.400
Why?
Medicare
20
2025
463
2.050
Why?
Comparative Effectiveness Research
5
2012
75
1.390
Why?
Hypertension
10
2023
1389
1.340
Why?
Aged
89
2025
21664
1.260
Why?
Retrospective Studies
71
2025
17413
1.250
Why?
Angiotensin-Converting Enzyme Inhibitors
6
2023
226
1.250
Why?
United States
68
2025
11645
1.240
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
7
2022
756
1.190
Why?
Protein Kinase Inhibitors
3
2023
608
1.160
Why?
Heart Failure
17
2016
2393
1.080
Why?
Breast Neoplasms
5
2023
2759
1.030
Why?
SEER Program
3
2024
224
1.000
Why?
Practice Patterns, Physicians'
8
2018
763
0.990
Why?
Antipsychotic Agents
12
2021
388
0.990
Why?
Diabetes Mellitus, Type 2
7
2025
1405
0.970
Why?
Risk
14
2017
831
0.950
Why?
Angiotensin Receptor Antagonists
5
2023
138
0.940
Why?
United States Department of Veterans Affairs
10
2012
705
0.930
Why?
Cholinergic Antagonists
7
2019
53
0.890
Why?
Proportional Hazards Models
11
2019
1478
0.870
Why?
Prescription Drugs
5
2019
59
0.840
Why?
Antihypertensive Agents
5
2012
409
0.810
Why?
Diabetes Mellitus
13
2023
932
0.790
Why?
Autoimmune Diseases
1
2024
278
0.760
Why?
Economics, Pharmaceutical
3
2009
9
0.740
Why?
Aged, 80 and over
33
2024
7183
0.740
Why?
Hospitals, Veterans
17
2007
357
0.730
Why?
Motivational Interviewing
4
2023
52
0.710
Why?
Databases, Factual
11
2024
1243
0.710
Why?
Comorbidity
16
2020
1606
0.700
Why?
Depression
12
2020
1348
0.700
Why?
Urinary Bladder, Overactive
4
2021
31
0.690
Why?
Hyperlipidemias
4
2022
200
0.680
Why?
Metformin
1
2022
162
0.680
Why?
Female
87
2025
71470
0.680
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
379
0.680
Why?
Cohort Studies
29
2022
5176
0.660
Why?
Selection Bias
2
2009
22
0.650
Why?
Humans
123
2025
133449
0.640
Why?
Nursing Homes
11
2019
97
0.630
Why?
Cardiovascular Diseases
6
2023
2077
0.630
Why?
Male
84
2025
65712
0.610
Why?
Dyslipidemias
2
2015
244
0.590
Why?
Risk Adjustment
5
2015
58
0.590
Why?
Protein-Tyrosine Kinases
1
2019
230
0.560
Why?
Medicare Part C
5
2023
39
0.550
Why?
Risk Assessment
8
2016
3682
0.550
Why?
Medicare Part D
4
2020
17
0.550
Why?
Epidemiologic Research Design
1
2016
6
0.520
Why?
Paroxetine
4
2017
29
0.520
Why?
Lung Neoplasms
2
2024
1791
0.500
Why?
Proton Pump Inhibitors
1
2019
285
0.490
Why?
Middle Aged
51
2025
29299
0.490
Why?
Veterans
11
2011
1764
0.480
Why?
Gastroesophageal Reflux
1
2019
337
0.480
Why?
Odds Ratio
5
2016
1337
0.480
Why?
Receptor, ErbB-2
3
2023
559
0.460
Why?
Multivariate Analysis
14
2016
1487
0.450
Why?
Medication Adherence
7
2025
338
0.450
Why?
Longitudinal Studies
7
2021
1486
0.430
Why?
Drug Utilization Review
3
2019
33
0.420
Why?
Logistic Models
16
2017
1905
0.400
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2023
1352
0.400
Why?
Managed Care Programs
3
2022
61
0.400
Why?
Cyclin-Dependent Kinase 4
2
2023
67
0.400
Why?
Hypoglycemic Agents
3
2025
478
0.390
Why?
Anti-Obesity Agents
1
2012
45
0.380
Why?
Antirheumatic Agents
2
2023
124
0.370
Why?
Losartan
1
2011
37
0.360
Why?
Biphenyl Compounds
1
2011
62
0.360
Why?
Tetrazoles
1
2011
64
0.360
Why?
Valine
1
2011
116
0.360
Why?
Pneumonia
3
2020
342
0.350
Why?
Benzimidazoles
1
2011
136
0.340
Why?
Case-Control Studies
14
2023
3632
0.340
Why?
Arthritis, Rheumatoid
2
2023
294
0.330
Why?
Insurance, Pharmaceutical Services
1
2009
10
0.330
Why?
Neoplasms
3
2020
3007
0.320
Why?
Guidelines as Topic
1
2011
200
0.320
Why?
Quality Indicators, Health Care
3
2019
233
0.320
Why?
Angioplasty
2
2007
80
0.310
Why?
Risk Factors
23
2017
11054
0.310
Why?
Survival Rate
5
2023
2199
0.310
Why?
Pharmaceutical Services
1
2009
38
0.310
Why?
Incidence
15
2019
3385
0.300
Why?
Data Interpretation, Statistical
4
2011
240
0.300
Why?
Baths
2
2020
16
0.300
Why?
Aortic Aneurysm, Abdominal
4
2007
444
0.300
Why?
Elective Surgical Procedures
3
2007
167
0.300
Why?
Multiple Sclerosis
2
2023
390
0.300
Why?
Propensity Score
7
2017
253
0.290
Why?
Research
3
2023
271
0.290
Why?
Anti-Infective Agents, Local
2
2020
69
0.280
Why?
Health Expenditures
3
2018
116
0.280
Why?
Prescription Drug Monitoring Programs
2
2017
9
0.280
Why?
Treatment Outcome
13
2023
12987
0.280
Why?
Accidental Falls
3
2016
126
0.270
Why?
Drug Utilization
3
2020
166
0.270
Why?
Diuretics
2
2005
170
0.270
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2006
319
0.270
Why?
Healthcare Disparities
1
2012
480
0.270
Why?
Leptospirosis
1
2006
6
0.270
Why?
Cholinesterase Inhibitors
3
2022
102
0.260
Why?
Quality of Health Care
5
2005
419
0.260
Why?
Fractures, Bone
3
2016
211
0.260
Why?
Drug-Related Side Effects and Adverse Reactions
4
2017
282
0.260
Why?
Dog Diseases
1
2006
61
0.250
Why?
Varenicline
2
2016
14
0.250
Why?
Data Collection
3
2016
397
0.250
Why?
Bupropion
2
2016
30
0.250
Why?
Antidepressive Agents, Second-Generation
2
2016
38
0.250
Why?
Adult
30
2024
31880
0.240
Why?
Inappropriate Prescribing
2
2015
36
0.240
Why?
Ethical Review
1
2005
3
0.240
Why?
Drug Therapy, Combination
6
2025
1199
0.240
Why?
Hospitalization
10
2012
1880
0.240
Why?
Analgesics, Opioid
3
2019
458
0.230
Why?
Ethics Committees, Research
1
2005
33
0.230
Why?
Diabetic Angiopathies
1
2005
72
0.230
Why?
Cross Infection
2
2020
332
0.230
Why?
Human Experimentation
1
2005
36
0.230
Why?
Medicaid
5
2025
254
0.230
Why?
Fingolimod Hydrochloride
2
2023
37
0.230
Why?
Opiate Substitution Treatment
1
2024
29
0.230
Why?
Internationality
3
2009
138
0.230
Why?
Alzheimer Disease
3
2022
872
0.230
Why?
Outpatients
1
2006
267
0.220
Why?
Drug Prescriptions
3
2019
237
0.220
Why?
Methadone
1
2024
125
0.220
Why?
Obesity
2
2015
2409
0.220
Why?
Polypharmacy
3
2019
40
0.220
Why?
Smoking Cessation
2
2016
209
0.220
Why?
Homes for the Aged
4
2017
25
0.220
Why?
Focus Groups
1
2024
214
0.220
Why?
Workload
1
2005
151
0.210
Why?
Cognitive Dysfunction
2
2019
309
0.210
Why?
Psychotic Disorders
3
2010
148
0.210
Why?
Education, Pharmacy
1
2024
61
0.210
Why?
Decision Making
4
2009
695
0.200
Why?
Cyclin-Dependent Kinase 6
1
2023
50
0.200
Why?
Diabetes Mellitus, Type 1
2
2010
862
0.200
Why?
Benzodiazepines
4
2017
110
0.200
Why?
Parkinson Disease
2
2020
727
0.190
Why?
Surgery Department, Hospital
1
2002
22
0.190
Why?
Postmenopause
1
2022
156
0.190
Why?
Cross-Sectional Studies
9
2020
3738
0.180
Why?
Hospital Mortality
3
2015
1072
0.180
Why?
Opioid-Related Disorders
1
2024
282
0.180
Why?
Medication Errors
2
2015
206
0.180
Why?
Biological Products
1
2023
137
0.180
Why?
Drug Interactions
2
2019
261
0.180
Why?
Kaplan-Meier Estimate
2
2023
1135
0.180
Why?
Health Status
3
2016
412
0.180
Why?
Patient Reported Outcome Measures
2
2020
203
0.170
Why?
Muscarinic Antagonists
4
2021
38
0.170
Why?
Chlorhexidine
2
2020
47
0.170
Why?
Depressive Disorder
3
2015
484
0.170
Why?
Intensive Care Units
4
2020
539
0.170
Why?
Cognition
2
2015
813
0.170
Why?
Health Maintenance Organizations
3
2009
24
0.170
Why?
Decision Support Techniques
2
2016
317
0.170
Why?
Psychotropic Drugs
2
2019
130
0.160
Why?
Advisory Committees
2
2011
158
0.160
Why?
Health Care Costs
1
2003
403
0.160
Why?
Chronic Disease
2
2016
1252
0.160
Why?
Health Services Accessibility
1
2024
648
0.160
Why?
Electronic Health Records
2
2020
789
0.160
Why?
Deprescriptions
1
2019
12
0.150
Why?
Lipids
1
2022
567
0.150
Why?
Patient Readmission
4
2016
411
0.150
Why?
Pharmacy Service, Hospital
1
2019
54
0.150
Why?
Models, Statistical
3
2015
505
0.150
Why?
Information Storage and Retrieval
1
2019
65
0.150
Why?
Drug Industry
1
2018
48
0.150
Why?
Peptic Ulcer
1
2019
151
0.140
Why?
Coronary Artery Bypass
1
2002
530
0.140
Why?
Diabetes Complications
4
2010
207
0.140
Why?
Health Services Research
3
2002
191
0.140
Why?
Texas
7
2023
3681
0.140
Why?
Prescription Drug Misuse
1
2017
9
0.140
Why?
Drug Costs
1
2018
67
0.140
Why?
Controlled Substances
1
2017
12
0.140
Why?
Health Policy
2
2009
228
0.140
Why?
Patient Discharge
4
2016
517
0.130
Why?
Patient Discharge Summaries
1
2016
10
0.130
Why?
Prospective Studies
9
2019
6649
0.130
Why?
Medication Therapy Management
1
2016
25
0.130
Why?
Age Factors
6
2015
2978
0.130
Why?
Regression Analysis
2
2009
831
0.130
Why?
Critical Care
2
2020
683
0.130
Why?
Dopamine Uptake Inhibitors
1
2015
36
0.120
Why?
Nicotinic Agonists
1
2015
45
0.120
Why?
Anti-Bacterial Agents
2
2020
2510
0.120
Why?
Southeastern United States
2
2006
40
0.120
Why?
Hip Fractures
1
2016
72
0.120
Why?
Tobacco Use Disorder
1
2016
97
0.120
Why?
Palliative Care
1
2019
457
0.120
Why?
Health Services Administration
2
2005
11
0.120
Why?
Diagnosis-Related Groups
1
1995
27
0.120
Why?
Physicians
2
2019
630
0.120
Why?
Hospital Information Systems
1
1995
46
0.120
Why?
Coronavirus Infections
1
2020
388
0.110
Why?
Pneumonia, Viral
1
2020
399
0.110
Why?
Methotrexate
3
2023
355
0.110
Why?
Residence Characteristics
3
2012
292
0.110
Why?
Health Services Needs and Demand
2
2015
181
0.110
Why?
Emergency Service, Hospital
3
2019
1145
0.110
Why?
Colistin
1
2014
33
0.110
Why?
Causality
2
2015
93
0.110
Why?
Lung Diseases, Obstructive
7
1999
34
0.110
Why?
Central Nervous System Stimulants
1
2014
131
0.110
Why?
Gram-Negative Bacterial Infections
1
2014
87
0.110
Why?
Health Personnel
1
2019
538
0.110
Why?
Community-Acquired Infections
1
2016
247
0.110
Why?
Health Resources
1
1995
125
0.110
Why?
Evidence-Based Medicine
2
2009
663
0.110
Why?
Administration, Oral
3
2021
727
0.110
Why?
Research Design
2
2011
755
0.110
Why?
Prevalence
5
2017
2654
0.110
Why?
Health Care Surveys
2
2012
292
0.110
Why?
Socioeconomic Factors
3
2015
919
0.110
Why?
Dementia, Vascular
2
2010
17
0.100
Why?
Weight Gain
1
2016
413
0.100
Why?
Mortality
1
2015
261
0.100
Why?
Mental Disorders
2
2019
878
0.100
Why?
Anxiety Disorders
2
2009
725
0.100
Why?
HIV Seroprevalence
1
1992
9
0.100
Why?
Observation
2
2010
45
0.100
Why?
California
3
2006
141
0.100
Why?
Substance-Related Disorders
1
2017
490
0.100
Why?
Sterilization, Tubal
1
1992
15
0.100
Why?
Housing
1
2012
54
0.100
Why?
Pandemics
1
2020
1192
0.100
Why?
Galantamine
2
2022
11
0.100
Why?
Rivastigmine
2
2022
18
0.100
Why?
Blood Vessels
1
2012
107
0.100
Why?
Nonlinear Dynamics
1
2012
53
0.100
Why?
Quality Assurance, Health Care
3
2007
222
0.100
Why?
Sex Factors
2
2015
1381
0.090
Why?
Attention Deficit Disorder with Hyperactivity
1
2014
231
0.090
Why?
Phenylcarbamates
2
2022
16
0.090
Why?
Hospitals
1
1995
428
0.090
Why?
Drug Therapy
2
2010
93
0.090
Why?
Models, Structural
1
2011
50
0.090
Why?
Valsartan
1
2011
23
0.090
Why?
Fosinopril
1
2011
3
0.090
Why?
Lisinopril
1
2011
23
0.090
Why?
Enalapril
1
2011
14
0.090
Why?
Captopril
1
2011
27
0.090
Why?
Reproducibility of Results
4
2016
3055
0.090
Why?
Indans
2
2022
56
0.090
Why?
Medication Systems, Hospital
1
2011
46
0.090
Why?
Adolescent
11
2023
20497
0.090
Why?
Students, Pharmacy
2
2024
71
0.090
Why?
Leg
2
2002
156
0.090
Why?
Pseudomonas Infections
1
2011
121
0.090
Why?
Nurses
1
2011
74
0.090
Why?
Blood Glucose
2
2025
1195
0.080
Why?
Pseudomonas aeruginosa
1
2011
176
0.080
Why?
Antineoplastic Agents
1
2020
1846
0.080
Why?
Predictive Value of Tests
1
2016
2302
0.080
Why?
Smoking
1
2015
1139
0.080
Why?
Follow-Up Studies
6
2019
5487
0.080
Why?
Piperidines
2
2022
238
0.080
Why?
Fee-for-Service Plans
1
2009
19
0.080
Why?
Epidemiologic Methods
1
2009
110
0.080
Why?
Cerebrovascular Disorders
1
2010
125
0.080
Why?
Young Adult
6
2024
9880
0.080
Why?
Vascular Surgical Procedures
2
2007
560
0.080
Why?
Sick Role
1
2009
32
0.080
Why?
Poverty
1
1992
435
0.080
Why?
Somatoform Disorders
1
2009
46
0.080
Why?
Insurance Coverage
1
2009
124
0.070
Why?
Cost of Illness
1
2010
275
0.070
Why?
Immunosuppressive Agents
2
2023
690
0.070
Why?
ROC Curve
1
2009
613
0.070
Why?
Bacteremia
1
2011
416
0.070
Why?
Iatrogenic Disease
2
1999
136
0.070
Why?
Kidney
1
2014
1405
0.070
Why?
Quetiapine Fumarate
3
2012
17
0.070
Why?
Demography
2
2006
247
0.070
Why?
Dibenzothiazepines
3
2012
15
0.070
Why?
Blood Vessel Prosthesis
1
2011
539
0.070
Why?
Survival Analysis
3
2009
1596
0.070
Why?
Risperidone
3
2012
60
0.060
Why?
Cyclooxygenase 2 Inhibitors
1
2006
54
0.060
Why?
Ambulatory Care
1
2009
412
0.060
Why?
Myocardial Ischemia
1
2009
363
0.060
Why?
Quality of Life
1
2016
2125
0.060
Why?
Environment
1
2006
155
0.060
Why?
Time Factors
5
2016
6578
0.060
Why?
Dogs
1
2006
800
0.060
Why?
Pulmonary Disease, Chronic Obstructive
2
2010
633
0.060
Why?
Oklahoma
1
2004
9
0.060
Why?
Evaluation Studies as Topic
1
2005
261
0.060
Why?
Academic Medical Centers
2
2016
333
0.060
Why?
National Institutes of Health (U.S.)
1
2005
141
0.060
Why?
Randomized Controlled Trials as Topic
1
2009
1198
0.060
Why?
Medical Records Systems, Computerized
1
2005
172
0.060
Why?
Hypolipidemic Agents
1
2006
187
0.050
Why?
Delivery of Health Care
1
2010
677
0.050
Why?
Narcotic Antagonists
1
2024
111
0.050
Why?
Buprenorphine
1
2024
100
0.050
Why?
Crotonates
1
2023
7
0.050
Why?
Dimethyl Fumarate
1
2023
11
0.050
Why?
Potassium Deficiency
1
2003
12
0.050
Why?
Interviews as Topic
1
2005
418
0.050
Why?
Netherlands
1
2003
47
0.050
Why?
Surgical Procedures, Operative
1
2005
187
0.050
Why?
Aortic Aneurysm, Thoracic
1
2011
677
0.050
Why?
Cross-Over Studies
1
2024
330
0.050
Why?
Cardiopulmonary Bypass
1
2005
358
0.050
Why?
Policy Making
1
2003
62
0.050
Why?
Colorectal Neoplasms
1
2009
649
0.050
Why?
Primary Health Care
1
2009
795
0.050
Why?
Pressure Ulcer
1
2003
79
0.050
Why?
Tolterodine Tartrate
1
2021
3
0.050
Why?
Surveys and Questionnaires
2
2024
3986
0.050
Why?
Linear Models
3
2016
723
0.050
Why?
Forecasting
1
2003
375
0.040
Why?
Educational Measurement
1
2024
337
0.040
Why?
Acetylcholinesterase
1
2021
26
0.040
Why?
Arterial Occlusive Diseases
1
2002
127
0.040
Why?
Qualitative Research
1
2024
636
0.040
Why?
Injections
1
2021
159
0.040
Why?
Benchmarking
1
2002
149
0.040
Why?
Hydroxychloroquine
1
2020
20
0.040
Why?
Glucocorticoids
1
2023
407
0.040
Why?
Brain
1
2012
3200
0.040
Why?
Azithromycin
1
2020
47
0.040
Why?
Soaps
1
2020
8
0.040
Why?
HIV Infections
1
1992
2059
0.040
Why?
Severity of Illness Index
3
2016
3065
0.040
Why?
Cost-Benefit Analysis
1
2003
565
0.040
Why?
Vascular Diseases
1
2001
158
0.040
Why?
Carcinoma, Hepatocellular
1
2009
995
0.040
Why?
Pharmacists
1
2020
99
0.040
Why?
Analysis of Variance
3
2011
1046
0.040
Why?
Cancer Pain
1
2019
28
0.040
Why?
Telephone
1
2019
127
0.040
Why?
Cholesterol, LDL
1
2022
604
0.040
Why?
Curriculum
1
2024
777
0.040
Why?
Liver Neoplasms
1
2009
1405
0.040
Why?
Gift Giving
1
2018
19
0.040
Why?
Motivation
2
2018
331
0.040
Why?
Length of Stay
3
2006
1374
0.040
Why?
Conflict of Interest
1
2018
69
0.030
Why?
Program Evaluation
1
2019
455
0.030
Why?
Pain Management
1
2019
201
0.030
Why?
Isocoumarins
1
2016
2
0.030
Why?
Coumarins
1
2016
24
0.030
Why?
Betacoronavirus
1
2020
309
0.030
Why?
Antidepressive Agents
1
2019
324
0.030
Why?
Medical Records
1
1997
194
0.030
Why?
Psychiatric Status Rating Scales
2
2010
849
0.030
Why?
Pneumonia, Ventilator-Associated
1
2016
44
0.030
Why?
Renal Dialysis
1
2003
875
0.030
Why?
Disease
1
1997
134
0.030
Why?
Tertiary Care Centers
1
2016
264
0.030
Why?
Catheter-Related Infections
1
2016
104
0.030
Why?
Infection Control
1
2016
151
0.030
Why?
Geography
1
2015
124
0.030
Why?
Health Services
1
1995
73
0.030
Why?
Behavior
1
2015
75
0.030
Why?
Myocardial Revascularization
1
1995
107
0.030
Why?
Fluorouracil
1
2015
141
0.030
Why?
Health Status Indicators
1
2015
129
0.030
Why?
Bias
1
1995
147
0.030
Why?
Insurance, Health
1
1995
144
0.030
Why?
Gram-Negative Bacteria
1
2014
72
0.030
Why?
Educational Status
1
2015
293
0.030
Why?
Surgical Wound Infection
1
2016
276
0.030
Why?
Angioplasty, Balloon, Coronary
1
1995
183
0.030
Why?
Cisplatin
1
2015
286
0.030
Why?
Disease Progression
2
2010
2235
0.030
Why?
Drug Resistance, Multiple, Bacterial
1
2014
144
0.030
Why?
Registries
1
2020
1558
0.030
Why?
Chi-Square Distribution
2
2006
604
0.030
Why?
Levonorgestrel
1
1992
21
0.020
Why?
Family Planning Services
1
1992
39
0.020
Why?
APACHE
3
1999
56
0.020
Why?
Attitude
1
1992
122
0.020
Why?
Time and Motion Studies
1
2011
22
0.020
Why?
Coronary Disease
1
1995
722
0.020
Why?
Prognosis
2
2011
5058
0.020
Why?
Insurance Claim Reporting
1
2010
8
0.020
Why?
Workflow
1
2011
133
0.020
Why?
Patient Care
1
2011
104
0.020
Why?
Pulmonary Medicine
1
2010
26
0.020
Why?
Utilization Review
1
2009
40
0.020
Why?
Health Services Misuse
1
2009
28
0.020
Why?
Confidence Intervals
1
2009
299
0.020
Why?
Asthma
1
2016
810
0.020
Why?
Emergency Medical Services
1
2012
415
0.020
Why?
Sex Distribution
1
2009
330
0.020
Why?
Serotonin Antagonists
1
2008
24
0.020
Why?
Coronary Artery Disease
1
1995
880
0.020
Why?
Age of Onset
1
2010
636
0.020
Why?
Age Distribution
1
2009
444
0.020
Why?
Prosthesis Design
1
2011
710
0.020
Why?
Reference Values
1
2009
744
0.020
Why?
Drug Administration Schedule
1
2009
753
0.020
Why?
Child
2
2019
25700
0.020
Why?
Observer Variation
2
1999
314
0.020
Why?
Neuropsychological Tests
1
2010
980
0.020
Why?
Infant, Newborn
1
2019
8570
0.020
Why?
Dose-Response Relationship, Drug
1
2009
1731
0.010
Why?
Anti-Ulcer Agents
1
2005
116
0.010
Why?
Animals
1
2006
36274
0.010
Why?
Referral and Consultation
1
2009
570
0.010
Why?
Schizophrenia
1
2008
332
0.010
Why?
Clinical Trials as Topic
1
2009
1153
0.010
Why?
Liver Diseases
1
2009
388
0.010
Why?
Minimally Invasive Surgical Procedures
1
2006
196
0.010
Why?
Infant
1
2019
13118
0.010
Why?
Diagnosis, Differential
1
2009
1963
0.010
Why?
Patient Selection
1
2007
732
0.010
Why?
Mass Screening
1
2009
832
0.010
Why?
Child, Preschool
1
2019
14758
0.010
Why?
Potassium
1
2003
288
0.010
Why?
Total Quality Management
1
2001
27
0.010
Why?
Intermittent Claudication
1
2002
60
0.010
Why?
Anxiety
1
2008
990
0.010
Why?
Activities of Daily Living
1
2002
431
0.010
Why?
Southwestern United States
1
1999
44
0.010
Why?
Medical History Taking
1
1999
118
0.010
Why?
Statistics, Nonparametric
1
1999
454
0.010
Why?
Practice Guidelines as Topic
1
2005
1329
0.010
Why?
Medical Audit
1
1997
101
0.010
Why?
Facility Regulation and Control
1
1995
1
0.010
Why?
Least-Squares Analysis
1
1995
36
0.010
Why?
Kidney Failure, Chronic
1
2003
911
0.010
Why?
Medically Uninsured
1
1995
76
0.010
Why?
Cardiac Output, Low
1
1995
68
0.010
Why?
Postoperative Complications
1
2006
3208
0.010
Why?
Program Development
1
1994
189
0.010
Why?
Delphi Technique
1
1994
242
0.010
Why?
Drug Implants
1
1992
44
0.010
Why?
Condoms
1
1992
50
0.010
Why?
Delayed-Action Preparations
1
1992
122
0.010
Why?
Sensitivity and Specificity
1
1997
2156
0.010
Why?
Patient Care Team
1
1994
572
0.010
Why?
JOHNSON's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (443)
Explore
_
Co-Authors (36)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_